{"id":"NCT02037477","sponsor":"Takeda","briefTitle":"Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)","officialTitle":"Phase 3 Open-Label Crossover Pharmacodynamic Study to Evaluate the Acid-inhibitory Effect of TAK-438 20 mg With Esomeprazole 20 mg or Rabeprazole Sodium 10 mg in Healthy Adult Male Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01","primaryCompletion":"2014-03","completion":"2014-03","firstPosted":"2014-01-16","resultsPosted":"2016-10-17","lastUpdate":"2016-10-17"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Healthy Volunteers"],"interventions":[{"type":"DRUG","name":"Vonoprazan","otherNames":["TAK-438","TakecabÂ®"]},{"type":"DRUG","name":"Esomeprazole","otherNames":["Nexium (esomeprazole)"]},{"type":"DRUG","name":"Rabeprazole sodium","otherNames":["Pariet (rabeprazole)"]}],"arms":[{"label":"Sequence A (Cohort 1): Vonoprazan + Esomeprazole","type":"EXPERIMENTAL"},{"label":"Sequence B (Cohort 1): Esomeprazole + Vonoprazan","type":"EXPERIMENTAL"},{"label":"Sequence C (Cohort 2): Vonoprazan + Rabeprazole Sodium","type":"EXPERIMENTAL"},{"label":"Sequence D (Cohort 2): Rabeprazole Sodium + Vonoprazan","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the acid-inhibitory effect of multiple oral doses of Vonoprazan (TAK-438) and the relative effect of vonoprazan versus two controls (esomeprazole and rabeprazole sodium) in healthy Japanese adult male participants with the CYP2C19 extensive metabolizer (EM) genotype.","primaryOutcome":{"measure":"Intragastric pH Time Course Over 24 Hours","timeFrame":"At baseline (Day -2 to Day -1), administration period (Days 1 to Day 2 and Days 7 to Day 8)","effectByArm":[{"arm":"Cohort 1 - Vonoprazan 20 mg","deltaMin":10.63,"sd":7.391},{"arm":"Cohort 1 - Esomeprazole 20 mg","deltaMin":10.63,"sd":7.391},{"arm":"Cohort 2 - Vonoprazan 20 mg","deltaMin":8.9,"sd":6.472},{"arm":"Cohort 2 - Rabeprazole Sodium 10 mg","deltaMin":8.9,"sd":6.472}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"MALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Nausea","Vomiting","Pyrexia","Rash"]}}